Table 3 Proportion of children with antibodies to malaria antigens
|  | Number of samples | AMA1 3D7 (%) | DBL1 3D7 | ID1–ID2a FCR3 | DBL2 FCR3 (%) | DBL3 FRC3 | DBL4 FCR3 (%) | DBL5 3D7 | DBL5 FCR3 | DBL6 FCR3 (%) | FV2 FCR3 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Ngali-Ntouessong village cohort (years) | |||||||||||
1–5 | 20 | 100 | 5% | 55% | 70 | 40% | 50 | 20% | 50% | 45 | 20% |
6–10 | 105 | 100 | 3% | 65% | 62 | 44% | 51 | 17% | 39% | 37 | 34% |
11–15 | 66 | 99 | 5% | 71% | 56 | 29% | 60 | 14% | 32% | 32 | 44% |
Girls 11–15 | 33 | 97 | 3% | 67% | 67 | 30% | 60 | 18% | 33% | 33 | 42% |
Severe malaria Yaoundé city cohort | |||||||||||
Healthy children | 42 | 36 | 5% | 7% | 12 | 10% | 12 | 2% | 5% | 7 | 14% |
Uncomplicated malaria | 41 | 78 | 0 | 7% | 20 | 5% | 10 | 2% | 0 | 7 | 2% |
Cerebral malaria | 15 | 100 | 0 | 0 | 27 | 13% | 13 | 0 | 20% | 40 | 0 |
Severe malaria anemia | 35 | 91 | 0 | 9% | 17 | 9% | 14 | 3% | 23% | 14 | 11% |
Other severe forms of malaria | 27 | 85 | 0 | 7% | 19 | 0 | 11 | 4% | 0 | 19 | 4% |